Page 257 - Multidisipliner Covid 19

COVID-19 Afl› Platformlar› ve Güncel Afl› Gelifltirme Çal›flmalar›

12. Yang ZY, Kong WP, Huang Y, et al. A DNA vaccine induces SARS
coronavirus neutralization and protective immunity in mice. Nature.
2004;428(6982):561-564. doi:10.1038/nature02463
13. Deming D, Sheahan T, Heise M, et al. Vaccine Efficacy in Senescent
Mice Challenged with Recombinant SARS-CoV Bearing Epidemic and
Zoonotic Spike Variants. 2006. doi:10.1371/journal.pmed.0030525
14. Ng O-W, Chia A, Tan AT, et al. Memory T cell responses targeting the
SARS coronavirus persist up to 11 years post-infection. Vaccine. 2016;
34:2008-2014. doi:10.1016/j.vaccine.2016.02.063
15. Faraz Ahmed S, Quadeer AA, McKay MR. Preliminary Identification
of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-
CoV-2) Based on SARS-CoV Immunological Studies. doi:10.3390/
v12030254
16. Sharpe HR, Gilbride C, Allen E, et al. The early landscape of COVID-
19 vaccine development in the UK and rest of the world. Immunology.
May 2020:imm.13222. doi:10.1111/imm.13222
17. Codagenix Announces the Synthesis and Preliminary Safety of Scalable,
Live-attenuated Vaccine Candidate Against COVID-19. https://www.
prnewswire.com/news-releases/codagenix-announces-the-synthesis-
and-preliminary-safety-of-scalable-live-attenuated-vaccine-candi
date-against-covid-19-301079306.html. Accessed June 22, 2020.
18. Lin J-T, Zhang J-S, Su N, et al. Safety and Immunogenicity from a Phase
I Trial of Inactivated Severe Acute Respiratory Syndrome Coronavirus Vac-
cine.; 1359.
19. Gao Q, Bao L, Mao H, et al. Development of an inactivated vaccine
candidate for SARS-CoV-2. Science (80- ). May 2020:eabc1932. doi:10.
1126/science.abc1932
20. Chen WH, Strych U, Hotez PJ, Bottazzi ME. The SARS-CoV-2 Vaccine
Pipeline: an Overview. Curr Trop Med Reports. 2020:1-4. doi:10.1007/
s40475-020-00201-6
21. Smith TRF, Patel A, Ramos S, et al. Immunogenicity of a DNA vaccine
candidate for COVID-19. Nat Commun. 2020;11(1):2601. doi:10.1038/
s41467-020-16505-0
22. J ONeill LA, Netea MG. BCG-induced trained immunity: can it offer
protection against COVID-19? Nat Rev Immunol. doi:10.1038/s41577-
020-0337-y
23. Rosales-Mendoza S, Márquez-Escobar VA, González-Ortega O, Nieto-

256